Product Information

APIDRA 100 UNIT/ML VIAL is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $8.1606 per ML under NDC 00088250033. Its NADAC has been published 665 times since Nov 28, 2013.

APIDRA 100 UNIT/ML VIAL

insulin glulisine
$8.1606per ML

Strength

100 [iU]/mL

NDC

00088250033

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

INSULIN GLULISINE

Approval Type

Biologic (BLA)

FDA Application

BLA021629

On Market Since

2/24/2009

Pharmacological Classes

Insulin Analog
Insulin [Chemical/Ingredient]

Price Statistics

The NADAC for APIDRA 100 UNIT/ML VIAL has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 39.5%. The table below summarizes its recorded NADAC range and movement.

Current price$8.1606 per ML
All-time high$27.2795 (Oct 16, 2019)
All-time low$8.1606 (Aug 19, 2026)
52-week high$8.1767
52-week low$8.1606
Median price$24.5424
Average price$21.2038
Largest weekly change-70.0% (Jan 3, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.0%

1M

-0.0%

3M

-0.2%

6M

-0.1%

1Y

-0.1%

3Y

-70.1%

5Y

-70.0%

All

-39.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of APIDRA 100 UNIT/ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for APIDRA 100 UNIT/ML VIAL, manufactured by Sanofi-Aventis U.S. LLC, is $8.1606 per ML (NDC 00088250033), effective Aug 19, 2026.

How has the price of APIDRA 100 UNIT/ML VIAL changed over time?

Over the history we have for it, the NADAC for APIDRA 100 UNIT/ML VIAL has declined 39.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for APIDRA 100 UNIT/ML VIAL?

Since Nov 28, 2013, the NADAC for APIDRA 100 UNIT/ML VIAL has ranged from a low of $8.1606 (Aug 19, 2026) to a high of $27.2795 (Oct 16, 2019), with a median of $24.5424 per ML.

Are there cheaper alternatives to APIDRA 100 UNIT/ML VIAL?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as APIDRA 100 UNIT/ML VIAL in a comparable dosage form, but none are currently priced below it.

Who manufactures APIDRA 100 UNIT/ML VIAL?

APIDRA 100 UNIT/ML VIAL (NDC 00088250033) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.